Literature DB >> 3219278

The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.

D I Jodrell1, A T Irvine, V R McCready, E Woodcraft, I E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3219278      PMCID： PMC2246815          DOI： 10.1038/bjc.1988.281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  The role of I-131-MIBG in the diagnosis and therapy of carcinoids.

Authors:  C A Hoefnagel; F C den Hartog Jager; B G Taal; N G Abeling; E E Engelsman
Journal:  Eur J Nucl Med       Date:  1987

2.  Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.

Authors:  M Fischer; D Kamanabroo; H Sonderkamp; T Proske
Journal:  Lancet       Date:  1984-07-21       Impact factor: 79.321

3.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

4.  Radiopharmaceutical treatment of malignant pheochromocytoma.

Authors:  J C Sisson; B Shapiro; W H Beierwaltes; J V Glowniak; M Nakajo; T J Mangner; J E Carey; D P Swanson; J E Copp; W G Satterlee
Journal:  J Nucl Med       Date:  1984-02       Impact factor: 10.057

5.  Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.

Authors:  T Sone; M Fukunaga; N Otsuka; R Morita; A Muranaka; S Yanagimoto; T Tomomitsu; H Nakayama; T Harada
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

6.  Meta-[I-131]iodobenzylguanidine uptake in a nonsecreting paraganglioma.

Authors:  A J Smit; L H van Essen; H Hollema; F A Muskiet; D A Piers
Journal:  J Nucl Med       Date:  1984-09       Impact factor: 10.057

7.  Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication.

Authors:  D M Wieland; L E Brown; M C Tobes; W L Rogers; D D Marsh; T J Mangner; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-04       Impact factor: 10.057
  7 in total
  2 in total

1.  131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection?

Authors:  A Osei-Bonsu; E M Kokoschka; W Ulrich; H Sinzinger
Journal:  Eur J Nucl Med       Date:  1989

Review 2.  Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1994-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.